JP2023527961A5 - - Google Patents

Info

Publication number
JP2023527961A5
JP2023527961A5 JP2022566301A JP2022566301A JP2023527961A5 JP 2023527961 A5 JP2023527961 A5 JP 2023527961A5 JP 2022566301 A JP2022566301 A JP 2022566301A JP 2022566301 A JP2022566301 A JP 2022566301A JP 2023527961 A5 JP2023527961 A5 JP 2023527961A5
Authority
JP
Japan
Prior art keywords
alkyl
group
compound
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022566301A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527961A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/030335 external-priority patent/WO2021222858A1/en
Publication of JP2023527961A publication Critical patent/JP2023527961A/ja
Publication of JP2023527961A5 publication Critical patent/JP2023527961A5/ja
Pending legal-status Critical Current

Links

JP2022566301A 2020-04-30 2021-04-30 gpr39タンパク質のアンタゴニスト Pending JP2023527961A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063018371P 2020-04-30 2020-04-30
US63/018,371 2020-04-30
PCT/US2021/030335 WO2021222858A1 (en) 2020-04-30 2021-04-30 Antagonists of gpr39 protein

Publications (2)

Publication Number Publication Date
JP2023527961A JP2023527961A (ja) 2023-07-03
JP2023527961A5 true JP2023527961A5 (https=) 2024-04-01

Family

ID=76035152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022566301A Pending JP2023527961A (ja) 2020-04-30 2021-04-30 gpr39タンパク質のアンタゴニスト

Country Status (6)

Country Link
US (1) US20230174484A1 (https=)
EP (1) EP4143163A1 (https=)
JP (1) JP2023527961A (https=)
KR (1) KR20230017787A (https=)
CN (1) CN115996908B (https=)
WO (1) WO2021222858A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4267580A1 (en) * 2020-12-22 2023-11-01 Pathios Therapeutics Limited N-(pyridin-2-yl)-6,7,8,9-tetrahydro-5h-5,8-epiminocyclohepta[c]pyridine-10-carboxamide derivatives and similar compounds as gpr65 modulators for the treatment of cancer
EP4486722A4 (en) * 2022-03-02 2026-03-25 Nico Therapeutics Inc COMPOUNDS, COMPOSITIONS AND PROCESSES
CN117224684A (zh) * 2023-09-27 2023-12-15 南京医科大学姑苏学院 Gpr39抑制剂在制备预防或治疗高血压疾病的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91418A (en) * 1988-09-01 1997-11-20 Rhone Poulenc Agrochimie (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
US20040071708A1 (en) 2002-09-26 2004-04-15 Immusol, Inc. GPR 39 modulators that control cancerous cell growth
WO2004099782A2 (en) * 2003-05-05 2004-11-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39)
US7459460B2 (en) * 2003-05-28 2008-12-02 Bristol-Myers Squibb Company Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
US7767680B2 (en) * 2004-11-03 2010-08-03 Vertex Pharmaceuticals Incorporated Ion channel modulators and methods of use
CN1850269A (zh) 2005-04-22 2006-10-25 中国科学院上海生命科学研究院 Gpr39基因在哺乳动物中枢神经系统的功能及其应用
MX2008015670A (es) 2006-06-08 2009-01-12 Janssen Pharmaceutica Nv Receptor 39 acoplado a proteina g (gpr39).
CN106103421B (zh) * 2014-02-14 2019-04-09 武田药品工业株式会社 Gpr6的吡嗪调节剂
KR20190097074A (ko) * 2016-12-27 2019-08-20 다이이찌 산쿄 가부시키가이샤 피리미딘 유도체

Similar Documents

Publication Publication Date Title
JP2023527961A5 (https=)
KR102800132B1 (ko) Sting 작동 화합물
CN106687450B (zh) 一种吲哚胺-2,3-双加氧酶抑制剂及其制备方法
CN101885722B (zh) 杂环炔苯类化合物及其药用组合物和应用
JP5865519B2 (ja) イミダゾピロリジノン化合物
JP2021523221A5 (https=)
KR102008635B1 (ko) 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
CN105646389B (zh) 一种作为吲哚胺-2,3-双加氧酶抑制剂的氨基磺酸脂及其制备方法和用途
CN103012399B (zh) 7-氧代吡啶并嘧啶类化合物及其药用组合物和应用
JP2019517487A5 (https=)
RU2015118647A (ru) Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr
JP2007511504A5 (https=)
KR20160115991A (ko) Midh1 억제제로서의 벤즈이미다졸-2-아민
RU2010154172A (ru) Соединения для лечения рака
JP2018536648A5 (https=)
JP2011524422A5 (https=)
JP2016526540A5 (https=)
JP2017533968A5 (https=)
WO2016082713A1 (zh) 2-氨基嘧啶类化合物及其药物组合物和应用
JP2021509678A5 (https=)
JP2022119852A5 (https=)
JP2020504186A5 (https=)
EP2714703A1 (en) Tricyclic inhibitors of poly(adp-ribose)polymerase
CN101747330A (zh) 吡啶基噻唑胺类化合物及其药用组合物和应用
JP2021514399A5 (https=)